Marksans Pharma Limited, along with its subsidiaries, is involved in the global research and development, manufacturing, marketing, and distribution of generic pharmaceutical formulations. The company offers a wide range of products in various therapeutic areas such as analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension. Established in 1992, Marksans Pharma Limited is headquartered in Mumbai, India.
Marksans Pharma Limited
- 254.45 2.00(0.79%) 253.25 0.85(0.34%)
Live Marksans Pharma Limited Share Price Chart
Marksans Pharma Limited Share Performance
| Today's Low | Today's High | |
|---|---|---|
| 252.15 252.00 | 260.70 260.55 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 130.00 (04-Jun-2024) 126.05 (14-Mar-2024) | 358.70 (02-Dec-2024) 358.50 (02-Dec-2024) |
- Open
- 252.90 255.35
- Previous Close
- 252.45 252.40
- Volume
- 6.91
- Total Traded value
- 17.74 (Lakhs)
- Upper circuit
- 302.90 195.70
- Lower circuit
- 202.00 130.50
Marksans Pharma Limited Share Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 5 | 0 |
| Bid Price | Quantity |
|---|---|
| 254.40 | 5.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 5 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Marksans Pharma Limited Share Fundamentals
| Market Cap: | 115.31 Cr |
| PE Ratio (TTM): | 74.45 |
| PB Ratio: | 8.86 |
| Industry P/E: | 32.93 |
| Debt to Equity: | - |
| ROE: | 11.89 |
| EPS (TTM): | 3.39 |
| Book Value: | 0.00 |
| Face Value: | 1.00 |
Marksans Pharma Limited Stock Financials
| Dec, 2022 | Sep, 2022 | Mar, 2023 | Sep, 2023 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 15,228.00 Cr | 351.10 Cr | 135.83 Cr | 358.51 Cr | 170.26 Cr |
| Profit | 2,505.00 Cr | 37.70 Cr | -9.61 Cr | 13.03 Cr | 40.23 Cr |
| Expense | 11,977.00 Cr | 321.00 Cr | 148.91 Cr | 342.66 Cr | 142.31 Cr |
| Comprehensive income | 2,536.00 Cr | 37.30 Cr | -9.44 Cr | 13.42 Cr | 40.24 Cr |
| EPS | 10.67 | 2.07 | -1.33 | 8.02 | 1.00 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Marksans Pharma Limited | Jan, 2002 Feb, 1994 | Pharmaceuticals Pharmaceuticals | MARKSANS MARKSANS |
Marksans Pharma Limited Stock Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Jan, 2023 Dec, 2022
Marksans Pharma Limited Share FAQ's
What is the range of today's stock performance for Marksans Pharma Limited?
Today's stock performance witnessed a fluctuation from a minimum of 252.15 on the NSE (National Stock Exchange) to a maximum of 260.70. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 252.00 to a high of 260.55.
What are the 52-week low and high values for Marksans Pharma Limited?
The stock's performance over the past 52 weeks reveals a low of 130.00 (occurred on 04-Jun-2024) and a high of 358.70 (achieved on 02-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 126.05 (on 14-Mar-2024), and the 52-week high is 358.50 (on 02-Dec-2024).
What was the opening and previous closing prices for Marksans Pharma Limited?
The stock's performance over the past 52 weeks reveals a low of 130.00 (occurred on 04-Jun-2024) and a high of 358.70 (achieved on 02-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 126.05 (on 14-Mar-2024), and the 52-week high is 358.50 (on 02-Dec-2024).
What is the total volume and traded value for Marksans Pharma Limited for the day?
The total volume is 7, and the total traded value is 17.74 ( Lakhs).
What are the upper and lower circuit limits for Marksans Pharma Limited?
The upper circuit limit is 302.90, and the lower circuit limit is 202.00.
What is the market cap and PE ratio for Marksans Pharma Limited?
The market cap is 115.31 Cr, and the PE ratio (TTM) is 32.93.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Marksans Pharma Limited?
ROE is 11.89, EPS is 3.39, book value is not available
What are the revenue and profit figures for the latest quarter and previous quarters for Marksans Pharma Limited?
In Dec 2022, Revenue is 152280000000.00, and Profit is 25050000000.00. In Sep 2022, Revenue is 3511000000, and Profit is 377000000.
When was Marksans Pharma Limited listed, and what industry does it belong to?
The company, Marksans Pharma Limited, was listed in Jan 2002 and belongs to the Pharmaceuticals industry. Its NSE symbol is MARKSANS.
What is the current shareholding pattern of the Marksans Pharma Limited?
As of latest available update, promoters hold 43.85%, the public holds 56.15%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 36
- Threads
- 195
